Archives

Monthly Archive for: "April, 2017"

Home /

By FDM Digital

In Company News

Posted 26th April 2017

NeRRe Therapeutics CEO, Dr Mary Kerr, will present at BioTrinity 2017, May 9th, London, UK, The title of the presentation is “NeRRe Therapeutics – a unique Neurokinin antagonist pipeline with the potential to return significant near-term value”

NeRRe Therapeutics is a UK based clinical-stage company developing a unique portfolio of neurokinin (NK) receptor antagonists for the treatment of common debilitating conditions caused by neuronal hypersensitivity.

Useful Links

Contact Us
About Us
Privacy Policy
Cookie Notice
Terms & Conditions
Clinical Trials Privacy Notice

Please fill out the form to get in touch with us.

I consent to NeRRe Therapeutics collecting my details through this form.

We are using cookies to give you the best experience on our website.

You can find out more about which cookies we are using or switch them off in .

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.

Strictly Necessary Cookies

Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.

Enable or Disable Cookies Enabled Disabled

3rd Party Cookies

This website uses Google Analytics to collect anonymous information such as the number of visitors to the site, and the most popular pages.

Keeping this cookie enabled helps us to improve our website.

Enable or Disable Cookies Enabled Disabled

Cookie Policy

More information about our Cookie Policy